Marker Therapeutics Inc. (MRKR)
NASDAQ: MRKR
· Real-Time Price · USD
1.24
-0.01 (-0.80%)
At close: Aug 15, 2025, 3:59 PM
1.26
1.61%
After-hours: Aug 15, 2025, 07:16 PM EDT
Marker Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -4.45M | -3.84M | -2.31M | -2.19M | -2.39M | -2.74M | -2.98M | -3.36M | -4.97M | -3.86M | -5.73M | -9.24M | -9.91M | -9.76M | -12.43M | -10.91M | -8.78M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | -971.73K | n/a | n/a | 971.73K | 965.01K | 1.04M | 838.95K | 834.22K | 820.18K | 805.25K | 782.83K | 754.37K |
Stock-Based Compensation | 379.14K | 50.54K | 53.3K | 62.6K | 79.42K | 143.37K | 175.04K | -120.06K | 659.91K | 717.17K | 935.36K | 355.73K | 1.63M | 1.47M | 1.47M | 1.65M | 1.38M |
Other Working Capital | n/a | 1.73M | 337.81K | -1.17M | -904.57K | 833.7K | 265.64K | 2.26M | -2.3M | 169.75K | -2.95M | 6.11M | -826.48K | -1.52M | -13.78K | -969.38K | 30.36K |
Other Non-Cash Items | n/a | -916.05K | 491.18K | n/a | 698.56K | -62.94K | -260.28K | -6.75M | 2.53M | -5.81M | -714.02K | 4.11M | 7.26M | 5.47M | -575.74K | 686.66K | 5.33M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | 2.53M | n/a | n/a | -2.53M | 5.81M | n/a | -4.11M | n/a | -5.47M | n/a | n/a | n/a |
Change in Working Capital | n/a | -916.05K | 2.96M | -1.44M | -1.52M | 292.11K | 1.94M | 3.17M | -2.55M | -4.13M | -175.94K | 6.11M | -4.78M | 2.62M | 3.64M | 1.63M | -2.41M |
Operating Cash Flow | -5.5M | -4.7M | 1.2M | -3.57M | -3.84M | -2.37M | -1.13M | -7.06M | -5.89M | -6.31M | -7.65M | -794.71K | -12.23M | -4.86M | -6.52M | -6.85M | -9.06M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 112.61K | -112.61K | -127.34K | -99.37K | -2.27M | -2.45M | -349.84K | -2M | -339.58K | -441.13K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | -18.66M | 18.66M | 18.66M | -112.61K | -127.34K | -99.37K | -2.27M | -1.63M | -1.56M | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | -18.66M | 18.66M | 18.78M | -112.61K | -127.34K | -99.37K | -2.27M | -2.45M | -349.84K | -2M | -339.58K | -441.13K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 505.00 | 3.66K | 1.7K | 7.7K | 49.1K | 5.13K | 84.61K | 736.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.09K | n/a |
Financial Cash Flow | 505.00 | 14.9M | 1.7K | 44.61K | 49.1K | 5.13K | 479.27K | 736.00 | 619.97K | 138.56K | n/a | 63.57K | n/a | n/a | n/a | -100.74K | 52.66M |
Net Cash Flow | -5.5M | 10.19M | 1.2M | -3.52M | -3.79M | -2.36M | -648.19K | 11.72M | -5.38M | -6.29M | -7.75M | -3M | -14.68M | -5.21M | -8.52M | -7.29M | 43.16M |
Free Cash Flow | -5.5M | -4.7M | 1.2M | -3.57M | -3.84M | -2.37M | -1.13M | -6.94M | -6M | -6.43M | -7.75M | -3.06M | -14.68M | -5.21M | -8.52M | -7.19M | -9.5M |